Transcranial Magnetic Stimulation in Primary Care: Indications, Risks, and Outcomes

References (34)

1. Fox MD, Buckner RL, White MP, et al. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 2012;72(7):595–603. PubMed CrossRef
2. Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol. 2021;132(1):269–306. PubMed CrossRef
3. Pell GS, Harmelech T, Zibman S, et al. Efficacy of deep TMS with the H1 coil for anxious depression. J Clin Med. 2022;11(4):1015. PubMed CrossRef
4. Petrosino NJ, Cosmo C, Berlow YA, et al. Transcranial magnetic stimulation for posttraumatic stress disorder. Ther Adv Psychopharmacol. 2021;11:20451253211049921. PubMed CrossRef
5. Lan L, Zhang X, Li X, et al. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. J Headache Pain. 2017;18(1):86. PubMed CrossRef
6. Ward HB, Mosquera MJ, Suzuki J, et al. A systematic review of noninvasive brain stimulation for opioid use disorder. Neuromodulation. 2020;23(3):301–311. PubMed CrossRef
7. Philip NS, Sorensen DO, McCalley DM, et al. Noninvasive brain stimulation for alcohol use disorders: state of the art and future directions. Neurotherapeutics. 2020;17(1):116–126. PubMed CrossRef
8. Zangen A, Moshe H, Martinez D, et al. Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial. World Psychiatry. 2021;20(3):397–404. PubMed CrossRef
9. Camprodon JA, Pascual-Leone A. Multimodal applications of transcranial magnetic stimulation for circuit-based psychiatry. JAMA Psychiatry. 2016;73(4):407–408. PubMed CrossRef
10. Somani A, Kar SK. Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far. Gen Psychiatr. 2019;32(4):e100074. PubMed CrossRef
11. Sehatzadeh S, Daskalakis ZJ, Yap B, et al. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades. J Psychiatry Neurosci. 2019;44(3):151–163. PubMed CrossRef
12. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587–596. PubMed CrossRef
13. Voigt JD, Leuchter AF, Carpenter LL. Theta burst stimulation for the acute treatment of major depressive disorder: a systematic review and meta-analysis. Transl Psychiatry. 2021;11(1):330. PubMed CrossRef
14. Wang WL, Wang SY, Hung HY, et al. Safety of transcranial magnetic stimulation in unipolar depression: a systematic review and meta-analysis of randomized-controlled trials. J Affect Disord. 2022;301:400–425. PubMed CrossRef
15. Rossi S, Hallett M, Rossini PM, et al; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–2039. PubMed CrossRef
16. Xia G, Gajwani P, Muzina DJ, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2008;11(1):119–130. PubMed CrossRef
17. Taylor JJ, Newberger NG, Stern AP, et al. Seizure risk with repetitive TMS: survey results from over a half-million treatment sessions. Brain Stimul. 2021;14(4):965–973. PubMed CrossRef
18. Ren J, Li H, Palaniyappan L, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:181–189. PubMed CrossRef
19. Mikellides G, Michael P, Psalta L, et al. A retrospective naturalistic study comparing the efficacy of ketamine and repetitive transcranial magnetic stimulation for treatment-resistant depression. Front Psychiatry. 2022;12:784830. PubMed CrossRef
20. Caulfield KA, Fleischmann HH, George MS, et al. A transdiagnostic review of safety, efficacy, and parameter space in accelerated transcranial magnetic stimulation. J Psychiatr Res. 2022;152:384–396. PubMed CrossRef
21. Cole EJ, Stimpson KH, Bentzley BS, et al. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression. Am J Psychiatry. 2020;177(8):716–726. PubMed CrossRef
22. Cole EJ, Phillips AL, Bentzley BS, et al. Stanford Neuromodulation Therapy (SNT): a double-blind randomized controlled trial. Am J Psychiatry. 2022;179(2):132–141. PubMed CrossRef
23. O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208–1216. PubMed CrossRef
24. Razafsha M, Barbour T, Uribe S, et al. Extension of transcranial magnetic stimulation treatment for depression in nonresponders: results of a naturalistic study. J Psychiatr Res. 2023;158:314–318. PubMed CrossRef
25. Hutton T, Carpenter L, Pages K, et al. Dosing transcranial magnetic stimulation: efficacy in major depressive disorder as a function of number of treatment sessions [abstract P1.154]. Brain Stimul. 2023;16(1):269–270. CrossRef
26. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014;75(12):1394–1401. PubMed CrossRef
27. Senova S, Cotovio G, Pascual-Leone A, et al. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimul. 2019;12(1):119–128. PubMed CrossRef
28. Wilson S, Croarkin PE, Aaronson ST, et al. Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS. J Affect Disord. 2022;296:79–88. PubMed CrossRef
29. Benadhira R, Thomas F, Bouaziz N, et al. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD). Psychiatry Res. 2017;258:226–233. PubMed CrossRef
30. Philip NS, Dunner DL, Dowd SM, et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 2016;9(2):251–257. PubMed CrossRef
31. Pridmore S, May T. Relapse prevention (RP) TMS. Brain Stimul. 2018;11(6):1391–1392. PubMed CrossRef
32. Wang HN, Wang XX, Zhang RG, et al. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Transl Psychiatry. 2017;7(12):1292. PubMed CrossRef
33. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–583. PubMed CrossRef
34. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMed CrossRef